Suchergebnisse - "Agbarya, Abed"

PubPharm (8)

1

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)

enthalten in: Journal of clinical medicine | 2022

von Raphael, A. | Dudnik, E. | Hershkovitz, D. | +10

2

Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future

enthalten in: Cancers | 2021

von Shalata, W. | Jacob, B. | Agbarya, A.

3

Treatment of Rare Mutations in Patients with Lung Cancer

enthalten in: Biomedicines | 2021

von Taha, T. | Khoury, R. | Brenner, R. | +4

4

Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer : A real-world evidence

enthalten in: International journal of cancer | 2021

von Dudnik, E. | Moskovitz, M. | Agbarya, A. | +11

5

First line Immunotherapy for Non-Small Cell Lung Cancer

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2020

von Nasser, N. | Gorenberg, M. | Agbarya, A.

6

BRAF Mutant Lung Cancer : Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2018

von Dudnik, E. | Peled, N. | Nechushtan, H. | +17

CommentIn: J Thorac Oncol. 2018 Aug;13(8):1055-1057. - PMID 30056857

7

Lower lung cancer rates in Jewish smokers in Israel and the USA

enthalten in: International journal of cancer | 2015

von Rennert, G. | Kremer, R. | Rennert, H. | +6

8

Lower lung cancer rates in Jewish smokers in Israel and the USA

enthalten in: International journal of cancer | 2015

von Lejbkowicz, F. | Wollner, M. | Kremer, R. | +6

1
[1]